Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
India
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dr. Aman Sharma
National cancer Institute, AIIMS, Jhajjar